Loading stock data…
$76.00-0.37 (-0.48%)
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services.
LivaNova PLC in the Healthcare sector is trading at $76.00 with a market capitalization of $4.3B. Wall Street consensus targets $90.55 (11 analysts), implying a +19.1% move over the next 12 months. The stock is currently 11% below its 52-week high of $85.76, remaining 5.7% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $390.59M↑ | $362.26M↑ | $360.92M↑ | $357.75M↑ | $352.52M |
| Gross Profit | $273.67M↑ | $243.75M↑ | $239.77M↓ | $244.85M↑ | $238.99M |
| Operating Income | $49.48M↑ | $41.47M↓ | $42.58M↓ | $54.01M↓ | $54.18M |
| Net Income | $108.57M↑ | $22.29M↓ | $30.91M↑ | $26.78M↓ | $27.16M |
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiop...